Vertex still knows how to do what it does best
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Top of the morning to you, and a fine one it is. Clear blue skies…
The blockbuster weight loss and diabetes drug sold by Eli Lilly also appears to improve…
WASHINGTON — As social media sites were flooded with misleading posts about vaccine safety, mask…
Millions of Americans’ bedtime routine includes wearing a mask attached to a respiratory machine that…
Johnson & Johnson faces a consequential new class action lawsuit — not in its role…
Novartis said late Monday it has agreed to buy German biotech MorphoSys and its pipeline…
Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health,…
WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s…
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
More than half of the injector-pen patents for several widely used diabetes treatments — including…
Sixteen billion dollars is a lot of money. But Monday’s announcement that the parent company…
After a months-long fight with Texas Medicaid over coverage of a gene therapy, Afghan refugees…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent…
Amgen is trying a unique strategy with its obesity drug candidate: testing whether it can…
The prediction is dire: Cancer cases around the world are expected to surge 77% by…
The Biden administration’s proposed minimum staffing standard is likely the most important nursing home reform…
Starting this year, private Medicare plans have to cover their members’ hospitalizations at the higher…
Katie Keim was diagnosed with type 1 diabetes in 1967 when she was eight, well…
At the end of each chapter in “Rebel Health: A Field Guide to the Patient-Led…
Devoted Health has been one of the most prominent health insurance and provider startups of…
Documents released this week shed new light on an aggressive strategy from vape maker Juul…
The Food and Drug Administration should move more quickly to ensure pulse oximeters — the…
ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3…
Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy,…
Since the 1920s, lead vests and aprons have served as trusted shields against the harmful…
Chicago pediatric hospital Lurie Children’s has been forced to take its network offline in the…
WASHINGTON — A bipartisan group of senators released a draft of legislation to resolve controversial…
Apple Vision Pro, the company’s most important new product in a decade, promises to envelop…
And so, another working week will soon draw to a close. Not a moment too…
Want to stay on top of the science and politics driving biotech today? Sign up to get…
I’ve spent a good deal of my career thinking about how we structure and fund…
Amid ongoing uncertainty about when abortions are permissible in Texas, the state’s medical board is…
Myopia, or near-sightedness, is on the rise: Nearly half of the world’s population will be…
Who among us is looking forward to getting older in 2024? Not senators (most of…
What makes a blockbuster? Can biotech learn from Aduhelm? And how do you replace a…
New data released Thursday by the Centers for Disease Control and Prevention suggest that the…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Researchers have long known that women are more likely to develop autoimmune disorders than men,…
MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under…
The federal government is unveiling new regulations meant to modernize methadone treatment, the first major…
Want to stay on top of the science and politics driving biotech today? Sign up to…
Rise and shine, everyone, another busy day is on the way. We can tell because…
WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its…
South Korea is the only country to officially recognize digital therapeutics as a category. Nevertheless,…
General Catalysts’s grand vision for a venture capital-owned hospital system seamlessly blending AI and tech…
Happy Groundhog Day eve. Some takes and thoughts on Bluebird Bio’s quest for gene therapy…
Last spring, I joined a rebellion. The entire editorial board of the prestigious scientific journal…